Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018150-26-000002

Options or other derivatives

  • Chief Science Officer Virology acquired 118,367 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Pauza Charles David Chief Science Officer Virology 2026-03-08 Grant or award · Stock Option (right to buy) +118,367 118,367 D: show line 1 in the form
Loading xslF345X05/form4-03102026_110321.xml…